Grocer banner

GlaxoSmithKline (GSK)

Share Price:
Down 1,646.20p
Change Today:
-5.60p
Market Cap:
82,124m

Latest ShareCast News

(Sharecast News) - easyJet: Kepler Cheuvreux downgrades to reduce with a target price of 820p.

(Sharecast News) - Beazley: UBS upgrades to buy with a target price of 650p.

(Sharecast News) - GlaxoSmithKline announced positive headline results from the pivotal 'DREAMM-2' open-label, randomised study of two doses of belantamab mafodotin on Friday.

(Sharecast News) - GlaxoSmithKline reported on Thursday that its specialist HIV company ViiV Healthcare had announced positive headline results from its phase 3 'ATLAS-2M' study of the investigational, long-acting, injectable, two-drug regimen (2DR) of its cabotegravir and Janssen's rilpivirine for the treatment of HIV.

(Sharecast News) - GlaxoSmithKline announced the submission of a Japanese New Drug Application (JNDA) to the Ministry of Health, Labour and Welfare on Wednesday, seeking marketing approval for \'daprodustat\'.

(Sharecast News) - Intercontinental Hotels: Berenberg downgrades to hold with a target price of 5,300p.

(Sharecast News) - GlaxoSmithKline has completed a transaction with Pfizer to combine their consumer healthcare businesses into a "world-leading" joint venture, it said on Thursday.

(Sharecast News) - GlaxoSmithKline (GSK) said on Monday that its ViiV Healthcare business has submitted a regulatory application to the European Medicines Agency for its HIV-prevention drug cabotegravir to be used alongside rilpivirine as the first ever monthly, injectable treatment for HIV.

(Sharecast News) - GlaxoSmithKline said on Wednesday that full-year earnings are set to drop less than it previously expected, as it posted a rise in second-quarter sales and profits.

(Sharecast News) - GlaxoSmithKline announced positive results from its \'PRIMA\' phase 3 randomised, double-blind, placebo-controlled study of \'Zejula\' (niraparib) as a maintenance therapy in patients with first-line ovarian cancer following platinum-based chemotherapy on Monday.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Market Data

Currency UK Pounds
Price 1,646.20p
Change Today -5.60p
52 Week High 1,745.20p
52 Week Low 1,418.00p
Volume 5,051,408
Shares Issued 4,988.72m
Market Cap 82,124m

Dividends

  Latest Previous
  Q2 Q1
Ex-Div 08-Aug-19 16-May-19
Paid 10-Oct-19 11-Jul-19
Amount 19.00p 19.00p